Can a spinal pump deliver better pain relief for pancreatic cancer?
NCT ID NCT07733427
First seen Jul 29, 2026 · Last updated Jul 31, 2026 · Updated 2 times
Summary
This pilot study tests whether delivering pain medication directly to the spinal cord via an implanted pump can better control severe pain in people with pancreatic cancer. The trial enrolls adults whose pain is not well managed by standard treatments or who cannot take typical painkillers. Researchers will track pain levels, opioid use, quality of life, sleep, and safety over 12 months to see if this approach offers meaningful relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- intrathecal analgesia via an implantable pump delivering pain medication directly to the spinal cord
- What this could lead to
- If effective, this approach could offer a new way to control severe pancreatic cancer pain that does not respond to standard treatments, potentially reducing opioid use and improving quality of life.
- What could go wrong
- This is a small pilot study with only 40 participants, so results may not apply broadly. The procedure carries risks such as infection, bleeding, or device malfunction, and it is unclear whether it will meaningfully reduce pain or opioid needs.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTRATHECAL ADMINISTRATION OF THE DRUG are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Benkessou
Paris, 75016, France
-
Bizet Clinic
Paris, 75016, France
-
Clinique Bizet
Paris, 75016, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- MRI screening may spot pancreatic cancer sooner in High-Risk gene carriers
- Lab-Made immune protein takes on advanced cancers in first human test
- Dye test may predict dangerous pancreatic leaks after surgery
- New PET tracer could spot cancers that standard scans overlook
- New eye on pancreatic cancer: Ultra-High resolution OCT could catch tumors at micrometer scale
- New drug combo targets tough pancreatic cancer gene